In the majority of ARMS tumors, a chromosomal translocation t(2;13) is identified, which leads to the expression of fusion proteins PAX3-FOXO1 or (less frequently) PAX7-FOXO1 [t(1;13)] (50). This evidence concerns the gene FOXO1 and alveolar rhabdomyosarcoma.